Beyond BCMA, why GPRC5D could be the right way: treatment strategies with immunotherapy at relapse after anti-BCMA agents

Del Giudice, ML; Galimberti, S; Buda, G

Del Giudice, ML (通讯作者),Univ Pisa, Dept Clin & Expt Med, Hematol, I-56126 Pisa, Italy.

CANCER IMMUNOLOGY IMMUNOTHERAPY, 2023; ():

Abstract

Multiple Myeloma remains incurable, and there is a need for therapies with novel mechanisms of action. Recently, B cell maturation antigen targeted th......

Full Text Link